These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 17990453)
21. Donepezil: in vascular dementia. Goldsmith DR; Scott LJ Drugs Aging; 2003; 20(15):1127-36. PubMed ID: 14651435 [TBL] [Abstract][Full Text] [Related]
22. P300 auditory event-related potentials and neuropsychological study during donepezil treatment in vascular dementia. Paci C; Gobbato R; Carboni T; Sanguigni S; Santone A; Curatola L Neurol Sci; 2006 Feb; 26(6):435-7. PubMed ID: 16601937 [TBL] [Abstract][Full Text] [Related]
23. [Donepezil in Alzheimer's disease and vascular dementia]. Damulin IV Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7):71-5. PubMed ID: 24073452 [No Abstract] [Full Text] [Related]
24. Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study. Dubois B; Tolosa E; Katzenschlager R; Emre M; Lees AJ; Schumann G; Pourcher E; Gray J; Thomas G; Swartz J; Hsu T; Moline ML Mov Disord; 2012 Sep; 27(10):1230-8. PubMed ID: 22915447 [TBL] [Abstract][Full Text] [Related]
25. Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation. Kudoh C; Arita R; Honda M; Kishi T; Komatsu Y; Asou H; Mimura M Psychogeriatrics; 2016 Mar; 16(2):85-92. PubMed ID: 25918972 [TBL] [Abstract][Full Text] [Related]
26. Combination of intensive cognitive rehabilitation and donepezil therapy in Alzheimer's disease (AD). Giordano M; Dominguez LJ; Vitrano T; Curatolo M; Ferlisi A; Di Prima A; Belvedere M; Barbagallo M Arch Gerontol Geriatr; 2010; 51(3):245-9. PubMed ID: 19969381 [TBL] [Abstract][Full Text] [Related]
27. Similar treatment outcomes with Ginkgo biloba extract EGb 761 and donepezil in Alzheimer's dementia in very old age: A retrospective observational study. Rapp M; Burkart M; Kohlmann T; Bohlken J Int J Clin Pharmacol Ther; 2018 Mar; 56(3):130-133. PubMed ID: 29319499 [TBL] [Abstract][Full Text] [Related]
28. Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group. Homma A; Takeda M; Imai Y; Udaka F; Hasegawa K; Kameyama M; Nishimura T Dement Geriatr Cogn Disord; 2000; 11(6):299-313. PubMed ID: 11044775 [TBL] [Abstract][Full Text] [Related]
30. A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease. Jones RW; Soininen H; Hager K; Aarsland D; Passmore P; Murthy A; Zhang R; Bahra R Int J Geriatr Psychiatry; 2004 Jan; 19(1):58-67. PubMed ID: 14716700 [TBL] [Abstract][Full Text] [Related]
31. An open-label, comparative study of rivastigmine, donepezil and galantamine in a real-world setting. Aguglia E; Onor ML; Saina M; Maso E Curr Med Res Opin; 2004 Nov; 20(11):1747-52. PubMed ID: 15537474 [TBL] [Abstract][Full Text] [Related]
32. Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting. Wallin AK; Andreasen N; Eriksson S; Båtsman S; Nasman B; Ekdahl A; Kilander L; Grut M; Rydén M; Wallin A; Jonsson M; Olofsson H; Londos E; Wattmo C; Eriksdotter Jonhagen M; Minthon L; Dement Geriatr Cogn Disord; 2007; 23(3):150-60. PubMed ID: 17312368 [TBL] [Abstract][Full Text] [Related]
33. Donepezil treatment of vascular dementia. Meyer JS; Chowdhury MH; Xu G; Li YS; Quach M Ann N Y Acad Sci; 2002 Nov; 977():482-6. PubMed ID: 12480789 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of donepezil treatment in Alzheimer patients with and without subcortical vascular lesions. Blasko I; Bodner T; Knaus G; Walch T; Monsch A; Hinterhuber H; Marksteiner J Pharmacology; 2004 Sep; 72(1):1-5. PubMed ID: 15292648 [TBL] [Abstract][Full Text] [Related]
35. Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease. Bullock R; Bergman H; Touchon J; Gambina G; He Y; Nagel J; Lane R Curr Med Res Opin; 2006 Mar; 22(3):483-94. PubMed ID: 16574032 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of Cholinesterase Inhibitors in Vascular Dementia: An Updated Meta-Analysis. Chen YD; Zhang J; Wang Y; Yuan JL; Hu WL Eur Neurol; 2016; 75(3-4):132-41. PubMed ID: 26918649 [TBL] [Abstract][Full Text] [Related]
37. Increased plasma donepezil concentration improves cognitive function in patients with dementia with Lewy bodies: An exploratory pharmacokinetic/pharmacodynamic analysis in a phase 3 randomized controlled trial. Mori E; Ikeda M; Nakai K; Miyagishi H; Nakagawa M; Kosaka K J Neurol Sci; 2016 Jul; 366():184-190. PubMed ID: 27288803 [TBL] [Abstract][Full Text] [Related]
38. Effects of the Acetylcholine Release Agent ST101 with Donepezil in Alzheimer's Disease: A Randomized Phase 2 Study. Gauthier S; Rountree S; Finn B; LaPlante B; Weber E; Oltersdorf T J Alzheimers Dis; 2015; 48(2):473-81. PubMed ID: 26402011 [TBL] [Abstract][Full Text] [Related]
39. [Clinical observation on acupuncture combined with Yizhi Jiannao granules for treatment of Alzheimer's disease]. Peng XW; Dong KL Zhongguo Zhen Jiu; 2009 Apr; 29(4):269-71. PubMed ID: 19565731 [TBL] [Abstract][Full Text] [Related]
40. [Effects of donepezil treatment on platelets α and β secretase activities in Alzheimer's disease patients]. Dong GS; Li X; Jiang QH; Yang HQ Zhonghua Yi Xue Za Zhi; 2011 Dec; 91(47):3341-5. PubMed ID: 22333201 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]